In addition, ERBB3 was downregulated in tumor (log2FC = 0.88, adjusted p-value ≤ 0.001), stromal (log2FC = 1.70, adjusted p-value ≤ 0.001), and immune (log2FC = 1.58, adjusted p-value ≤ 0.001) regions of the NR group (Table S2). This evidence concerns the gene ERBB3 and neoplasm.